Page 7 - Amarin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Around the house: ABB poaches Holcim’s legal head as latest GC, US firetruck-maker REV Group ends GC hunt

Company maintains positive cash flow for fifth consecutive quarter

Amarin (NASDAQ:AMRN – Get Free Report) and Roche (OTCMKTS:RHHBY – Get Free Report) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, risk, analyst recommendations, profitability, earnings, dividends and valuation. Volatility and Risk Amarin has a beta of 1.87, indicating […]

Amarin (NASDAQ:AMRN – Get Free Report) and Roche (OTCMKTS:RHHBY – Get Free Report) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, institutional ownership, dividends, earnings, valuation and risk. Valuation and Earnings This table compares Amarin and Roche’s top-line […]

StockNews.com assumed coverage on shares of Amarin (NASDAQ:AMRN – Free Report) in a report issued on Thursday. The firm issued a hold rating on the biopharmaceutical company’s stock. AMRN has been the subject of a number of other research reports. Northland Securities reduced their price objective on Amarin from $2.00 to $1.25 in a report […]